Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Pharmacol Ther. 2016 Mar 19;161:79–96. doi: 10.1016/j.pharmthera.2016.03.003

Figure 2. Therapeutic candidates targeting tumor-stromal interactions and enhancing host immune response of mBC.

Figure 2

This schematic diagram illustrates severeal key stromal cell populations important for regulating the growth of mBC, as well as therapeutic agents available or being developed to target the molecular pathways that mediate tumor-stromal interactions.